Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence

The need to rapidly spread information about the risk of COVID-19 in patients with psoriasis and psoriatic arthritis on biologics may have hampered the methodological rigor in published literature. We analyzed the quality of papers dealing with the risk and outcomes of COVID-19 in patients with psor...

Descripción completa

Detalles Bibliográficos
Autores principales: Piaserico, Stefano, Gisondi, Paolo, Cazzaniga, Simone, Di Leo, Sara, Naldi, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334343/
https://www.ncbi.nlm.nih.gov/pubmed/34363826
http://dx.doi.org/10.1016/j.jid.2021.04.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334343/
https://www.ncbi.nlm.nih.gov/pubmed/34363826
http://dx.doi.org/10.1016/j.jid.2021.04.036

Ejemplares similares